NDC properties for "tetracycline HCl 3 % Topical Ointment" (RxCUI 1542813)
About this data
The tables show NDC propoerties for tetracycline HCl 3 % Topical Ointment with the RxCUI 1542813
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline HCl 3 % Topical Ointment (RxCUI 1542813)
MMSL_CODE | BD5415 |
---|---|
MMSL_CODE | CD5415 |
RxCUI | 1542813 |
SPL_SET_ID | 01c726c5-2538-4ec2-bca3-4fb8c461233d |
SPL_SET_ID | 1c6c18db-5e42-4942-a611-00d49651a91f |
SPL_SET_ID | 2601650a-1870-4fe5-9931-842fb2381c94 |
SPL_SET_ID | 2c2b4ce1-2a54-4ff4-a660-14629a3df69f |
SPL_SET_ID | 3a5e4a8e-20bb-4bf8-8a2e-8dfd7f2afb49 |
SPL_SET_ID | 4ac5177d-bb67-45e6-adcf-44f0821746bd |
SPL_SET_ID | 647918a1-f49f-ef01-e053-2a91aa0a11fb |
SPL_SET_ID | 9215ec6b-69df-4b7d-b426-af50955d2c7c |
SPL_SET_ID | 9b3c7b34-abd9-417b-a2e9-b7e857339ff5 |
SPL_SET_ID | a6630858-7038-425f-8a75-bb25f36a0dbe |
SPL_SET_ID | ab95442b-9a0d-ecd5-e053-2a95a90a8007 |
SPL_SET_ID | b1c971ef-848c-6276-e053-2a95a90ac5c1 |
SPL_SET_ID | d277e34c-bf05-42a4-9bbf-860cba62d060 |
SPL_SET_ID | e1f206fb-ffa0-01a8-e053-2995a90ae448 |
VUID | 4001922 |
Prescribable Synonym | tetracycline HCl 3 % Topical Ointment |
RXNAV_STR | tetracycline hydrochloride 0.03 MG/MG Topical Ointment |
RxNorm Name | tetracycline hydrochloride 0.03 MG/MG Topical Ointment |
RxNorm Synonym | tetracycline HCl 3 % Topical Ointment |
Related queries | Interactions (for RxCUI 1542813) |
NDC Properties
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
NDC 9 | 43074-103 |
---|---|
NDC 10 | 43074-103-01 |
NDC Item | 43074010301 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30125 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
NDC 9 | 43074-108 |
---|---|
NDC 10 | 43074-108-01 |
NDC Item | 43074010801 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 30283 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2010-08-24 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
NDC 9 | 43074-115 |
---|---|
NDC 10 | 43074-115-01 |
NDC Item | 43074011501 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38806 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
NDC 9 | 43074-116 |
---|---|
NDC 10 | 43074-116-01 |
NDC Item | 43074011601 |
Packaging | 3 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 38788 |
Labeler | Phillips Company |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH FINAL |
Marketing effective time low | 2011-02-15 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_FINAL | part333B |
Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
NDC 9 | 69006-011 |
---|---|
NDC 10 | 69006-011-00 |
NDC Item | 69006001100 |
Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750209 |
Labeler | Viaderma II, Inc |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-05-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-00 |
NDC Item | 71262000200 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-01 |
NDC Item | 71262000201 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-02 |
NDC Item | 71262000202 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
NDC 9 | 71262-002 |
---|---|
NDC 10 | 71262-002-15 |
NDC Item | 71262000215 |
Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750578 |
Labeler | ViaDerma Distribution, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2016-11-08 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
NDC 9 | 71262-009 |
---|---|
NDC 10 | 71262-009-01 |
NDC Item | 71262000901 |
Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
FDA SPL set id | 801037 |
Labeler | VIADERMA DISTRIBUTION INC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2024-05-01 |
Marketing status | active |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
NDC 9 | 72053-000 |
---|---|
NDC 10 | 72053-000-00 |
NDC Item | 72053000000 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750517 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2018-04-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
NDC 9 | 72053-002 |
---|---|
NDC 10 | 72053-002-01 |
NDC Item | 72053000201 |
Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
FDA SPL set id | 750595 |
Labeler | Patient Focused Tele-Health, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-09-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
NDC 9 | 79790-000 |
---|---|
NDC 10 | 79790-000-00 |
NDC Item | 79790000000 |
Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
FDA SPL set id | 750404 |
Labeler | WOUNDS PROS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2020-07-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
NDC 9 | 82776-000 |
---|---|
NDC 10 | 82776-000-15 |
NDC Item | 82776000015 |
Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
FDA SPL set id | 753734 |
Labeler | THE WOUND DOCS, LLC |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time low | 2022-06-01 |
Marketing status | ACTIVE |
OTC_MONOGRAPH_DRUG | M004 |
Related queries | Properties for NDC 9 82776-000 |